Position in NVO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$71,546,275
+$49,896,595 QoQ
Shares Held
1,492,413
+153.3% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#45
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Derivatives in NVO
reported options exposure · as of Mar 31, 2021CallValue
$0
CallShares
0
PutValue
$3,371,000
PutShares
100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANK OF MONTREAL /CAN/ holds $6,780,882,947 across 16 Drug Manufacturers - General names. NVO ranks #11 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,724,702 | $2,068,659,488 | |
| 2 | JNJ |
Johnson & Johnson
|
4,646,972 | $1,180,191,474 | |
| 3 | ABBV |
AbbVie Inc.
|
3,470,007 | $873,192,557 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,565,728 | $715,196,045 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,772,428 | $476,608,548 | |
| 6 | AZN |
Astrazeneca PLC
|
2,359,807 | $447,466,599 | |
| 7 | AMGN |
Amgen Inc
|
882,230 | $319,473,122 | |
| 8 | GSK |
GSK plc
|
4,042,863 | $211,926,875 |
All Filings in NVO
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,546,275 | 1,492,413 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $21,649,680 | 589,107 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $128,514,075 | 2,525,827 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $58,676,122 | 1,057,418 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $170,845,202 | 2,475,300 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $85,330,159 | 1,228,833 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $148,207,037 | 1,722,937 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $133,488,421 | 1,121,092 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $171,331,819 | 1,200,307 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $178,296,365 | 1,388,601 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $138,675,549 | 1,340,508 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $126,923,956 | 1,395,689 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $125,200,262 | 773,653 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $119,444,911 | 750,565 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $95,036,964 | 702,209 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $63,654,900 | 638,913 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $78,170,928 | 701,525 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $70,634,906 | 636,064 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $68,543,328 | 611,994 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $60,464,792 | 629,776 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $51,905,815 | 619,623 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $14,090,643 | 208,998 | Shares | Defined | 2021-05-13 | |
| 2021-03-31 | $3,371,000 | 50,000 | Put | Defined | 2021-05-13 | |
| 2020-12-31 | $18,532,529 | 265,319 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $17,501,356 | 252,072 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $11,035,342 | 168,530 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $10,546,315 | 175,188 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||